Investors & Media

The investor relations section of Selvita S.A. is addressed to all capital market participants and media, and in particular to our shareholders, analysts, individual and institutional investors interested in our company.

You’ll be able to find here the latest information on our financial results, current operations and development plans, as well as a range of other useful information. If there is anything more you should need, don’t hesitate to contact us!

Investors & Media

Overview

Selvita share price [PLN]

News feed

Selvita to acquire Fidelta from Galapagos <br/>- Strengthening Selvita’s position as one of the largest preclinical contract research organizations in Europe -
23 November 2020

Selvita to acquire Fidelta from Galapagos
- Strengthening Selvita’s position as one of the largest preclinical contract research organizations in Europe -

Continue reading
Selvita reports strong financial results for Q3 2020
13 November 2020

Selvita reports strong financial results for Q3 2020

Continue reading
Selvita will participate in the upcoming 5th Medicinal Chemistry & Protein Degradation Summit
12 November 2020

Selvita will participate in the upcoming 5th Medicinal Chemistry & Protein Degradation Summit

Continue reading

Reports

Show
  • 24 November 2020

    Report ESPI QSr 3/2020

    Selvita Group Consolidated Quarterly Report 2020 Q3 (Summary)
  • 10 September 2020

    Report ESPI PSr 2020

    Consolidated Semiannual Report Selvita Group 2019 H1 (Summary)
  • 26 May 2020

    Report ESPI QSr 1/2020

    Selvita Group Consolidated Quarterly Report 2020 Q1 (Summary)
  • 26 March 2020

    Report ESPI – RS 2019

    Selvita Group Consolidated Annual Report (Summary) 2019
  • 07 November 2019

    Raport ESPI SA-Q 3/2019

    Selvita S.A. Quarterly Report 2019 Q3 (Summary)

Financial results

Operating revenues**
2020
Show

* Presented data for particular periods of 2018-2019 show the financial results achieved by the Separated Part (CRO) in the individual periods of 2018-2019 and demonstrate how the Selvita S.A. Group financial data would look like if the corporate split had happened on January 1, 2018.

** Revenues from sales + revenues from grants + remaining operating revenues

Operating profit/EBIT
2020
Show
EBIDTA
2020
Show
Net profit
2020
Show

Shareholder structure

Share in capital
Share in votes
ShareholderShare in capitalShare in votes
Paweł Przewięźlikowski
Bogusław Sieczkowski
Augebit FIZ*
Nationale Nederlanden OFE
Remaining Management Board and Supervisory Board Members
Remaining Shareholders
* the beneficiary of Augebit FIZ is Tadeusz Wesołowski – Vice Chairman of Selvita Supervisory Board; information based on the number of shares from the last notification provided by the shareholder to the Company (without taking into account the dilution resulting from the issue of H shares).

Corporate information

PDF icon
Selvita S.A. Articles of Association
selvita_logo

    Contacts